Finding migraine relief is rarely one-size-fits-all. Doctors usually divide treatment into two buckets: acute medicines that stop an attack in its tracks and preventive therapies that reduce how often headaches strike. Your best plan depends on frequency, severity, and triggers—and on practical details like timing, side effects, insurance coverage, and how medications can be combined [1][2].
Acute Relief Versus Prevention
Acute treatments are for “right now”—taken at the earliest sign of pain, aura, or nausea. They include triptans, gepants, NSAIDs, antiemetics, and, for some, ditans [1][2]. Preventive medicines are taken regularly to cut down monthly migraine days and make attacks easier to treat when they do occur.
Many people need both: a solid preventive to lower the baseline, plus a reliable acute option to restore function quickly when a breakthrough attack hits. Finding what works often means revisiting this balance over time as patterns, life stressors, or hormones shift. If headaches occur more than 4–8 days per month, or acute meds are used too often, it’s a signal to consider prevention—and to learn how to avoid medication overuse headache (MOH) before it quietly worsens the cycle [1][3].
Fast-Acting Options Explained
Triptans (such as sumatriptan, rizatriptan, and eletriptan) remain first-line for many adults without cardiovascular disease because they can halt pain and light/sound sensitivity within 2–4 hours when taken early [1][2][5]. NSAIDs like naproxen or ibuprofen can be effective alone or as add-ons. Can you take a triptan and an NSAID together? Yes—there’s even an FDA-approved combo of sumatriptan plus naproxen, which can improve sustained relief for some patients, though it also raises NSAID-related risks like stomach irritation or elevated blood pressure [4]. Ask your clinician if this strategy fits your health profile.
Most triptans, NSAIDs, and gepants (ubrogepant, rimegepant) have a low risk of sedation compared with ditans like lasmiditan, which can impair driving for at least 8 hours [2][5]. If sumatriptan stops working, it may help to take it earlier, try a faster formulation (nasal spray or injection), switch to another triptan, or add an NSAID. If triptans are ineffective or not tolerated, gepants or ditans are typical next steps [2][4][5].
To protect against MOH, limit acute meds to the fewest days necessary—often cited as no more than 10 days per month for triptans and combination products, and 15 days for simple analgesics—while building a preventive plan if attacks are frequent [1][3].
Preventive Therapies To Consider
Preventive medicines lower attack frequency and intensity so acute drugs work better. Traditional options include beta blockers (propranolol, metoprolol), anticonvulsants (topiramate, valproate), and certain antidepressants (amitriptyline, venlafaxine) [6]. For chronic migraine (15+ headache days/month), prevention often includes onabotulinumtoxinA (Botox) injections and, increasingly, CGRP-targeting therapies [6][7]. For women of childbearing potential, discuss pregnancy safety—valproate is generally avoided.
Vestibular migraine—where dizziness or vertigo dominate—uses similar principles. The best medication for vestibular migraine depends on symptoms and comorbidities; clinicians often try topiramate, venlafaxine, verapamil, or beta blockers preventively, with standard acute options during attacks, although high-quality trials are limited [8]. A neurology or headache specialist can tailor therapy, especially for disabling vertigo, balance issues, or frequent aura.
Newer CGRP Targeted Choices
CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab) are designed specifically for migraine pathways and are given monthly or quarterly to prevent attacks. Gepants block the CGRP receptor in pill or orally disintegrating tablet form: ubrogepant and rimegepant are used acutely; rimegepant (every other day) and atogepant (daily) prevent migraines [2]. Compared with triptans, these agents don’t constrict blood vessels, making them options for people who can’t take triptans due to cardiovascular risks [2].
In practice, triptans often deliver higher 2‑hour pain-freedom rates for people who respond to them and take them early, while gepants tend to be better tolerated and useful for patients who don’t respond to—or shouldn’t use—triptans [2][9][10]. If you’re deciding between Nurtec ODT (rimegepant) and Ubrelvy (ubrogepant) for acute migraine, both show meaningful relief by 2 hours in clinical trials. Nurtec ODT is a single dissolving tablet with optional every‑other‑day preventive use; Ubrelvy allows a second dose within 24 hours if needed. Side effects are typically mild (including nausea and fatigue) [9][10].
Coverage is improving, but prior authorization is common. It helps to document what you’ve tried, how well it worked, and any contraindications. Manufacturer copay cards may reduce costs for some commercially insured patients; Medicare and Medicaid coverage varies by plan.
Decades of use suggest triptans are generally safe in appropriate patients, with most adverse effects (tingling, flushing, tightness) being brief. Rare vascular events can occur, so they’re avoided in uncontrolled hypertension, coronary disease, or stroke history. Overuse can still trigger MOH—another reason to pair effective prevention with judicious acute use [2][5].
Practical Tips And Decisions
- Match meds to your pattern: infrequent but disabling attacks favor strong acute options; frequent attacks point to prevention plus a reliable rescue.
- Treat early. The earlier you take an acute drug, the better the chance of pain freedom and normal function [1][2].
- Clarify combinations: can you take a triptan and an NSAID together? Yes—if your clinician approves and you have no contraindications [4].
- Learn how to avoid medication overuse headache by tracking days of use, spacing doses, and leaning on prevention when monthly days creep up [1][3].
- Consult a specialist if attacks are frequent, atypical (e.g., prominent vestibular symptoms), or if you’ve failed two or more acute or preventive classes [2].
Resources
[1] American Migraine Foundation. Acute and Preventive Treatment Options. https://americanmigrainefoundation.org/resource-library/acute-and-preventive-treatment/
[2] American Headache Society. Position Statement: Integrating new migraine treatments into clinical practice. https://headachejournal.onlinelibrary.wiley.com/doi/10.1111/head.14082
[3] American Migraine Foundation. Medication Overuse Headache. https://americanmigrainefoundation.org/resource-library/medication-overuse-headache/
[4] FDA. TREXIMET (sumatriptan and naproxen) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021926s012lbl.pdf
[5] FDA. IMITREX (sumatriptan) Prescribing Information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020080s050lbl.pdf
[6] AAN/AHS Guideline Update: Pharmacologic treatment for episodic migraine prevention in adults. https://www.aan.com/Guidelines/home/GetGuidelineContent/599
[7] AAN. OnabotulinumtoxinA for Prevention of Chronic Migraine. https://www.aan.com/Guidelines/home/GetGuidelineContent/898
[8] Bárány Society/International Headache Society. Vestibular Migraine Diagnostic Criteria Update. https://pubmed.ncbi.nlm.nih.gov/33594667/
[9] Dodick DW et al. Ubrogepant for Acute Treatment of Migraine. N Engl J Med. 2019. https://www.nejm.org/doi/full/10.1056/NEJMoa1813049
[10] Lipton RB et al. Rimegepant for Acute Treatment of Migraine. N Engl J Med. 2019. https://www.nejm.org/doi/full/10.1056/NEJMoa1811090